As of 2024-12-14, the Relative Valuation of Gemini Therapeutics Inc (GMTX) is (19.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Gemini Therapeutics Inc based on Relative Valuation is -1553.0%.
The range of the Relative Valuation is (20.32) - (20.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 24.1x | 17.3x |
| Forward P/E multiples | 18.8x - 19.2x | 19.0x |
| Fair Price | (20.32) - (20.71) | (19.62) |
| Upside | -1605.0% - -1633.9% | -1553.0% |
| Date | P/E |